All In MedTech

Device Trial Radar · NCT04790344

LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study (LUX-Dx TRENDS)

Last checked: Nov 21, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

557

Actual

Start

Mar 20, 2021

Primary completion

Jul 27, 2026

Study completion Jul 27, 2026

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Mar 10, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.

Conditions

  • Heart Failure

Interventions

  • Investigational LUX-Dx ICM ImplantDevice

    All subject will receive an investigational version of the LUX-Dx ICM device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Heart Failure Event Related Data will be assessed in all subjects through collection of reportable events and subsequent adjudication by the CEC.Time frame: Through study completion of approximately 4.5 year

Locations

57 sites in 1 country. Site status is shown where the registry gives one.

  • Grandview Medical Center - Affinity Hospital, LLC

    Birmingham, Alabama

56 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.